カテゴリー： QYResearch, 世界

世界の末期腎不全（ESRD）薬市場 2019年

【英語タイトル】Global End-Stage Renal Disease (ESRD) Drugs Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X07327）・商品コード：DATA909X07327
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：106
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、末期腎不全（ESRD）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、コハク酸カルシウム、Mk-3866、パクリチニブ、サンギネート、テシドールマブ、その他に、用途別には、病院、診療所、ICU、その他にセグメント区分し、末期腎不全（ESRD）薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・末期腎不全（ESRD）薬の世界市場概要
・末期腎不全（ESRD）薬の製造コスト構成分析
・末期腎不全（ESRD）薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・末期腎不全（ESRD）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・末期腎不全（ESRD）薬のセグメント分析（種類別）
（コハク酸カルシウム、Mk-3866、パクリチニブ、サンギネート、テシドールマブ、その他）
・末期腎不全（ESRD）薬のセグメント分析（用途別）
（病院、診療所、ICU、その他）
・末期腎不全（ESRD）薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（CTI BioPharma Corp、Merck & Co Inc、Novartis AG、Prolong Pharmaceuticals LLC、VESSL Therapeutics Ltd、）
・末期腎不全（ESRD）薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global End-Stage Renal Disease (ESRD) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on End-Stage Renal Disease (ESRD) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall End-Stage Renal Disease (ESRD) Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of End-Stage Renal Disease (ESRD) Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their End-Stage Renal Disease (ESRD) Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
CTI BioPharma Corp
Merck & Co Inc
Novartis AG
Prolong Pharmaceuticals LLC
VESSL Therapeutics Ltd
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Calcium Succinate
Mk-3866
Pacritinib
Sanguinate
Tesidolumab
Others

Segment by Application
Hospital
Clinic
ICU
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of End-Stage Renal Disease (ESRD) Drugs
1.1 Definition of End-Stage Renal Disease (ESRD) Drugs
1.2 End-Stage Renal Disease (ESRD) Drugs Segment by Type
1.2.1 Global End-Stage Renal Disease (ESRD) Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Calcium Succinate
1.2.3 Mk-3866
1.2.4 Pacritinib
1.2.5 Sanguinate
1.2.6 Tesidolumab
1.2.7 Others
1.3 End-Stage Renal Disease (ESRD) Drugs Segment by Applications
1.3.1 Global End-Stage Renal Disease (ESRD) Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 ICU
1.3.5 Others
1.4 Global End-Stage Renal Disease (ESRD) Drugs Overall Market
1.4.1 Global End-Stage Renal Disease (ESRD) Drugs Revenue (2014-2025)
1.4.2 Global End-Stage Renal Disease (ESRD) Drugs Production (2014-2025)
1.4.3 North America End-Stage Renal Disease (ESRD) Drugs Status and Prospect (2014-2025)
1.4.4 Europe End-Stage Renal Disease (ESRD) Drugs Status and Prospect (2014-2025)
1.4.5 China End-Stage Renal Disease (ESRD) Drugs Status and Prospect (2014-2025)
1.4.6 Japan End-Stage Renal Disease (ESRD) Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Status and Prospect (2014-2025)
1.4.8 India End-Stage Renal Disease (ESRD) Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of End-Stage Renal Disease (ESRD) Drugs
2.3 Manufacturing Process Analysis of End-Stage Renal Disease (ESRD) Drugs
2.4 Industry Chain Structure of End-Stage Renal Disease (ESRD) Drugs

3 Development and Manufacturing Plants Analysis of End-Stage Renal Disease (ESRD) Drugs
3.1 Capacity and Commercial Production Date
3.2 Global End-Stage Renal Disease (ESRD) Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of End-Stage Renal Disease (ESRD) Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 End-Stage Renal Disease (ESRD) Drugs Production and Capacity Analysis
4.2 End-Stage Renal Disease (ESRD) Drugs Revenue Analysis
4.3 End-Stage Renal Disease (ESRD) Drugs Price Analysis
4.4 Market Concentration Degree

5 End-Stage Renal Disease (ESRD) Drugs Regional Market Analysis
5.1 End-Stage Renal Disease (ESRD) Drugs Production by Regions
5.1.1 Global End-Stage Renal Disease (ESRD) Drugs Production by Regions
5.1.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Regions
5.2 End-Stage Renal Disease (ESRD) Drugs Consumption by Regions
5.3 North America End-Stage Renal Disease (ESRD) Drugs Market Analysis
5.3.1 North America End-Stage Renal Disease (ESRD) Drugs Production
5.3.2 North America End-Stage Renal Disease (ESRD) Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America End-Stage Renal Disease (ESRD) Drugs Import and Export
5.4 Europe End-Stage Renal Disease (ESRD) Drugs Market Analysis
5.4.1 Europe End-Stage Renal Disease (ESRD) Drugs Production
5.4.2 Europe End-Stage Renal Disease (ESRD) Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe End-Stage Renal Disease (ESRD) Drugs Import and Export
5.5 China End-Stage Renal Disease (ESRD) Drugs Market Analysis
5.5.1 China End-Stage Renal Disease (ESRD) Drugs Production
5.5.2 China End-Stage Renal Disease (ESRD) Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China End-Stage Renal Disease (ESRD) Drugs Import and Export
5.6 Japan End-Stage Renal Disease (ESRD) Drugs Market Analysis
5.6.1 Japan End-Stage Renal Disease (ESRD) Drugs Production
5.6.2 Japan End-Stage Renal Disease (ESRD) Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan End-Stage Renal Disease (ESRD) Drugs Import and Export
5.7 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Market Analysis
5.7.1 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Production
5.7.2 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Import and Export
5.8 India End-Stage Renal Disease (ESRD) Drugs Market Analysis
5.8.1 India End-Stage Renal Disease (ESRD) Drugs Production
5.8.2 India End-Stage Renal Disease (ESRD) Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India End-Stage Renal Disease (ESRD) Drugs Import and Export

6 End-Stage Renal Disease (ESRD) Drugs Segment Market Analysis (by Type)
6.1 Global End-Stage Renal Disease (ESRD) Drugs Production by Type
6.2 Global End-Stage Renal Disease (ESRD) Drugs Revenue by Type
6.3 End-Stage Renal Disease (ESRD) Drugs Price by Type

7 End-Stage Renal Disease (ESRD) Drugs Segment Market Analysis (by Application)
7.1 Global End-Stage Renal Disease (ESRD) Drugs Consumption by Application
7.2 Global End-Stage Renal Disease (ESRD) Drugs Consumption Market Share by Application (2014-2019)

8 End-Stage Renal Disease (ESRD) Drugs Major Manufacturers Analysis
8.1 CTI BioPharma Corp
8.1.1 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Production Sites and Area Served
8.1.2 CTI BioPharma Corp Product Introduction, Application and Specification
8.1.3 CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Merck & Co Inc
8.2.1 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Production Sites and Area Served
8.2.2 Merck & Co Inc Product Introduction, Application and Specification
8.2.3 Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Novartis AG
8.3.1 Novartis AG End-Stage Renal Disease (ESRD) Drugs Production Sites and Area Served
8.3.2 Novartis AG Product Introduction, Application and Specification
8.3.3 Novartis AG End-Stage Renal Disease (ESRD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Prolong Pharmaceuticals LLC
8.4.1 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Production Sites and Area Served
8.4.2 Prolong Pharmaceuticals LLC Product Introduction, Application and Specification
8.4.3 Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 VESSL Therapeutics Ltd
8.5.1 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Production Sites and Area Served
8.5.2 VESSL Therapeutics Ltd Product Introduction, Application and Specification
8.5.3 VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served

9 Development Trend of Analysis of End-Stage Renal Disease (ESRD) Drugs Market
9.1 Global End-Stage Renal Disease (ESRD) Drugs Market Trend Analysis
9.1.1 Global End-Stage Renal Disease (ESRD) Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 End-Stage Renal Disease (ESRD) Drugs Regional Market Trend
9.2.1 North America End-Stage Renal Disease (ESRD) Drugs Forecast 2019-2025
9.2.2 Europe End-Stage Renal Disease (ESRD) Drugs Forecast 2019-2025
9.2.3 China End-Stage Renal Disease (ESRD) Drugs Forecast 2019-2025
9.2.4 Japan End-Stage Renal Disease (ESRD) Drugs Forecast 2019-2025
9.2.5 Southeast Asia End-Stage Renal Disease (ESRD) Drugs Forecast 2019-2025
9.2.6 India End-Stage Renal Disease (ESRD) Drugs Forecast 2019-2025
9.3 End-Stage Renal Disease (ESRD) Drugs Market Trend (Product Type)
9.4 End-Stage Renal Disease (ESRD) Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 End-Stage Renal Disease (ESRD) Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of End-Stage Renal Disease (ESRD) Drugs
Table Global End-Stage Renal Disease (ESRD) Drugs Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global End-Stage Renal Disease (ESRD) Drugs Production Market Share by Types in 2018
Figure Calcium Succinate Product Picture
Figure Mk-3866 Product Picture
Figure Pacritinib Product Picture
Figure Sanguinate Product Picture
Figure Tesidolumab Product Picture
Figure Others Product Picture
Table Global End-Stage Renal Disease (ESRD) Drugs Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global End-Stage Renal Disease (ESRD) Drugs Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure ICU
Figure Others
Figure Global End-Stage Renal Disease (ESRD) Drugs Revenue (Million USD) (2014-2025)
Figure Global End-Stage Renal Disease (ESRD) Drugs Production (K Pcs) (2014-2025)
Figure North America End-Stage Renal Disease (ESRD) Drugs Market Size (Million USD) (2014-2025)
Figure Europe End-Stage Renal Disease (ESRD) Drugs Market Size (Million USD) (2014-2025)
Figure China End-Stage Renal Disease (ESRD) Drugs Market Size (Million USD) (2014-2025)
Figure Japan End-Stage Renal Disease (ESRD) Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia End-Stage Renal Disease (ESRD) Drugs Market Size (Million USD) (2014-2025)
Figure India End-Stage Renal Disease (ESRD) Drugs Market Size (Million USD) (2014-2025)
Table End-Stage Renal Disease (ESRD) Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of End-Stage Renal Disease (ESRD) Drugs in 2018
Figure Manufacturing Process Analysis of End-Stage Renal Disease (ESRD) Drugs
Figure Industry Chain Structure of End-Stage Renal Disease (ESRD) Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global End-Stage Renal Disease (ESRD) Drugs Manufacturing Plants Distribution
Table End-Stage Renal Disease (ESRD) Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table End-Stage Renal Disease (ESRD) Drugs Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table End-Stage Renal Disease (ESRD) Drugs Production (K Pcs) of Major Manufacturers (2014-2019)
Table End-Stage Renal Disease (ESRD) Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure End-Stage Renal Disease (ESRD) Drugs Production Share by Manufacturers in 2018
Table End-Stage Renal Disease (ESRD) Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table End-Stage Renal Disease (ESRD) Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure End-Stage Renal Disease (ESRD) Drugs Revenue Share by Manufacturers in 2018
Table End-Stage Renal Disease (ESRD) Drugs Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global End-Stage Renal Disease (ESRD) Drugs Production by Regions 2014-2019 (K Pcs)
Table Global End-Stage Renal Disease (ESRD) Drugs Production Market Share by Regions 2014-2019
Figure Global End-Stage Renal Disease (ESRD) Drugs Production Market Share by Regions in 2018
Table Global End-Stage Renal Disease (ESRD) Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Regions 2014-2019
Figure Global End-Stage Renal Disease (ESRD) Drugs Revenue Market Share by Regions in 2018
Table Global End-Stage Renal Disease (ESRD) Drugs Consumption by Regions 2014-2019 (K Pcs)
Table Global End-Stage Renal Disease (ESRD) Drugs Consumption Market Share by Regions 2014-2019
Figure North America End-Stage Renal Disease (ESRD) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure North America End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America End-Stage Renal Disease (ESRD) Drugs Production, Consumption Import and Export (K Pcs)
Figure Europe End-Stage Renal Disease (ESRD) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Europe End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe End-Stage Renal Disease (ESRD) Drugs Production, Consumption Import and Export (K Pcs)
Figure China End-Stage Renal Disease (ESRD) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure China End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China End-Stage Renal Disease (ESRD) Drugs Production, Consumption Import and Export (K Pcs)
Figure Japan End-Stage Renal Disease (ESRD) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Japan End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan End-Stage Renal Disease (ESRD) Drugs Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia End-Stage Renal Disease (ESRD) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia End-Stage Renal Disease (ESRD) Drugs Production, Consumption Import and Export (K Pcs)
Figure India End-Stage Renal Disease (ESRD) Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure India End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India End-Stage Renal Disease (ESRD) Drugs Production, Consumption Import and Export (K Pcs)
Figure Global Consumption End-Stage Renal Disease (ESRD) Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) End-Stage Renal Disease (ESRD) Drugs Market Share by Application (2014-2019)
Table CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Production Sites and Area Served
Table CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Product Introduction, Application and Specification
Table CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Production Growth Rate (2014-2019)
Table CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Production Market Share (2014-2019)
Figure CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Revenue Market Share (2014-2019)
Table CTI BioPharma Corp End-Stage Renal Disease (ESRD) Drugs Main Business and Markets Served
Table Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Production Sites and Area Served
Table Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Product Introduction, Application and Specification
Table Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Production Growth Rate (2014-2019)
Table Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Production Market Share (2014-2019)
Figure Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Revenue Market Share (2014-2019)
Table Merck & Co Inc End-Stage Renal Disease (ESRD) Drugs Main Business and Markets Served
Table Novartis AG End-Stage Renal Disease (ESRD) Drugs Production Sites and Area Served
Table Novartis AG End-Stage Renal Disease (ESRD) Drugs Product Introduction, Application and Specification
Table Novartis AG End-Stage Renal Disease (ESRD) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis AG End-Stage Renal Disease (ESRD) Drugs Production Growth Rate (2014-2019)
Table Novartis AG End-Stage Renal Disease (ESRD) Drugs Production Market Share (2014-2019)
Figure Novartis AG End-Stage Renal Disease (ESRD) Drugs Revenue Market Share (2014-2019)
Table Novartis AG End-Stage Renal Disease (ESRD) Drugs Main Business and Markets Served
Table Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Production Sites and Area Served
Table Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Product Introduction, Application and Specification
Table Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Production Growth Rate (2014-2019)
Table Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Production Market Share (2014-2019)
Figure Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Revenue Market Share (2014-2019)
Table Prolong Pharmaceuticals LLC End-Stage Renal Disease (ESRD) Drugs Main Business and Markets Served
Table VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Production Sites and Area Served
Table VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Product Introduction, Application and Specification
Table VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Production Growth Rate (2014-2019)
Table VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Production Market Share (2014-2019)
Figure VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Revenue Market Share (2014-2019)
Table VESSL Therapeutics Ltd End-Stage Renal Disease (ESRD) Drugs Main Business and Markets Served
Figure Global End-Stage Renal Disease (ESRD) Drugs Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global End-Stage Renal Disease (ESRD) Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global End-Stage Renal Disease (ESRD) Drugs Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America End-Stage Renal Disease (ESRD) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe End-Stage Renal Disease (ESRD) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China End-Stage Renal Disease (ESRD) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan End-Stage Renal Disease (ESRD) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia End-Stage Renal Disease (ESRD) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India End-Stage Renal Disease (ESRD) Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India End-Stage Renal Disease (ESRD) Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of End-Stage Renal Disease (ESRD) Drugs by Type (2019-2025)
Table Global Consumption (K Pcs) of End-Stage Renal Disease (ESRD) Drugs by Application (2019-2025)
Table End-Stage Renal Disease (ESRD) Drugs Distributors List
Table End-Stage Renal Disease (ESRD) Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

CTI BioPharma Corp、Merck & Co Inc、Novartis AG、Prolong Pharmaceuticals LLC、VESSL Therapeutics Ltd、

★調査レポート[世界の末期腎不全（ESRD）薬市場 2019年] (コード：DATA909X07327)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の末期腎不全（ESRD）薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の腎細胞がん薬市場 2019年
    DATA909X14276 / QYResearch / 2019年11月20日 / ※本調査レポートは、腎細胞がん薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、Sutent（スニチニブ）、Nexavar（ソラフェニブ）、Votrient（パゾパニブ）、Avastin（ベバシズマブ）、Afinitor（エベロリムス）、Inlyta（アキシチニブ）、Torisel（テムシロリムス）、Proleukin（アルデスロイキン）に、用途別には、粘液性尿細管および紡錘細胞癌（MTSCC）、多房性嚢胞性明細胞腎細胞癌、尿細管嚢胞腎細胞癌、甲状腺様濾胞腎細胞癌、その他にセグメント区分し、腎細胞がん薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・腎細胞がん薬の世界市場概要 ・腎細胞がん薬の製造コスト構成分析 ・腎細胞がん薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・腎細胞がん薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・腎細胞がん薬のセグメント分析（種類別） （Sutent（スニチニブ）、Nexavar（ソラフェニブ）、Votrient（パゾパニブ）、Avastin（ベバシズマブ）、Afinitor（エベロリムス）、Inlyta（アキシチニブ）、Torisel（テムシロリムス）、Proleukin（アルデスロイキン））...The global Renal Cell Cacinoma Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Renal Cell Cacinoma Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Renal Cell Cacinoma Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Renal Cell Cacinoma Drugs in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界のポンペ病治療薬市場 2019年
    DATA909X13429 / QYResearch / 2019年11月20日 / ※本調査レポートは、ポンペ病治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、肝臓薬、心臓薬、筋肉薬に、用途別には、病院、診療所、その他にセグメント区分し、ポンペ病治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・ポンペ病治療薬の世界市場概要 ・ポンペ病治療薬の製造コスト構成分析 ・ポンペ病治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ポンペ病治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ポンペ病治療薬のセグメント分析（種類別） （肝臓薬、心臓薬、筋肉薬）...The global Pompe Disease Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Pompe Disease Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pompe Disease Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Pompe Disease Drugs in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆